Ichrogene Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$2.6M
- Investors
-
6
Ichrogene General Information
Description
Developer of a genetic information analysis platform designed to give DNA trait analysis for healthcare. The company uses personal genetic information to provide a gene service and tracks accurate DNA data and individual gene constitution analysis, enabling genome analysts and researchers to improve the accuracy of SNP analysis.
Contact Information
Website
www.ichrogene.co.krCorporate Office
- 249, 211, Chuam-ro, Buk-gu
- Wolchul-dong, Techno Park
- Gwangju
- South Korea
Corporate Office
- 249, 211, Chuam-ro, Buk-gu
- Wolchul-dong, Techno Park
- Gwangju
- South Korea
Ichrogene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 01-May-2021 | $2.6M | Completed | Generating Revenue | ||
| 4. Seed Round | 15-Jan-2020 | Completed | Generating Revenue | |||
| 3. Equity Crowdfunding | 01-Jun-2019 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Corporate | 01-Jan-2019 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ichrogene Patents
Ichrogene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025084481-A1 | Method for selecting genetic high-risk group for type 2 diabetes by considering genetic variants associated with obesity and type 2 diabetes | Inactive | 20-Oct-2023 | ||
| US-20200160935-A1 | Cloud-based gene analysis service method and platform | Inactive | 20-Nov-2018 |
Ichrogene Signals
Ichrogene Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Insight Equity Partners | Venture Capital | Minority | ||
| 365mc | Corporation | Minority | ||
| Genopsy | VC-Backed Company | Minority | ||
| NAVER D2SF | Corporate Venture Capital | Minority | ||
| Korea Credit Guarantee Fund | Venture Capital | Minority |
Ichrogene FAQs
-
When was Ichrogene founded?
Ichrogene was founded in 2017.
-
Where is Ichrogene headquartered?
Ichrogene is headquartered in Gwangju, South Korea.
-
What is the size of Ichrogene?
Ichrogene has 3 total employees.
-
What industry is Ichrogene in?
Ichrogene’s primary industry is Enterprise Systems (Healthcare).
-
Is Ichrogene a private or public company?
Ichrogene is a Private company.
-
What is Ichrogene’s current revenue?
The current revenue for Ichrogene is .
-
How much funding has Ichrogene raised over time?
Ichrogene has raised $3.66M.
-
Who are Ichrogene’s investors?
Insight Equity Partners, 365mc, Genopsy, NAVER D2SF, and Korea Credit Guarantee Fund are 5 of 6 investors who have invested in Ichrogene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process